1-(4-(4-(((2r,5r)-2-((1H-imidazol-1-yl)methyl)-2-(2-chlorophenyl)-1,3-dioxan-5-yloxy)methyl)phenyl)piperazin-1-yl)ethanone

ID: ALA4285744

Max Phase: Preclinical

Molecular Formula: C27H31ClN4O4

Molecular Weight: 511.02

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(=O)N1CCN(c2ccc(CO[C@H]3CO[C@@](Cn4ccnc4)(c4ccccc4Cl)OC3)cc2)CC1

Standard InChI:  InChI=1S/C27H31ClN4O4/c1-21(33)31-12-14-32(15-13-31)23-8-6-22(7-9-23)16-34-24-17-35-27(36-18-24,19-30-11-10-29-20-30)25-4-2-3-5-26(25)28/h2-11,20,24H,12-19H2,1H3/t24-,27+

Standard InChI Key:  KXAVEJVPHQCMQP-FEGDYQJNSA-N

Molfile:  

     RDKit          2D

 36 40  0  0  0  0  0  0  0  0999 V2000
   33.4063   -6.6540    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.4052   -7.4814    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.1200   -7.8942    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.8365   -7.4809    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.8335   -6.6503    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.1182   -6.2413    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.6925   -6.2419    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.6943   -5.4159    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   31.9838   -5.0037    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.2670   -5.4128    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.2653   -6.2387    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.9803   -6.6556    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   32.6869   -7.0666    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.9698   -7.4742    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.2170   -7.1390    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.6608   -7.7483    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.0685   -8.4655    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.8766   -8.2994    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.5541   -4.9978    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   29.8381   -5.4078    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.1252   -4.9928    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.1315   -4.1679    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.4193   -3.7529    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.7025   -4.1629    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.7021   -4.9922    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.4149   -5.4034    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.9889   -3.7488    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.9947   -2.9262    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.2853   -2.5122    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.5675   -2.9197    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.5636   -3.7456    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.2777   -4.1641    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.8556   -2.5029    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.8605   -1.6780    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   24.1386   -2.9111    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.1157   -5.4163    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  7  8  1  0
  7 12  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
  1  7  1  0
  7 13  1  6
 13 14  1  0
 17 18  2  0
 15 16  2  0
 14 15  1  0
 16 17  1  0
 18 14  1  0
 10 19  1  1
 19 20  1  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 21  1  0
 24 27  1  0
 27 28  1  0
 27 32  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 30 33  1  0
 33 34  2  0
 33 35  1  0
  6 36  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4285744

    ---

Associated Targets(Human)

CYP21A2 Tchem Cytochrome P450 21 (835 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP17A1 Tclin Cytochrome P450 17A1 (3627 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 511.02Molecular Weight (Monoisotopic): 510.2034AlogP: 3.69#Rotatable Bonds: 7
Polar Surface Area: 69.06Molecular Species: NEUTRALHBA: 7HBD:
#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 6.42CX LogP: 3.62CX LogD: 3.59
Aromatic Rings: 3Heavy Atoms: 36QED Weighted: 0.48Np Likeness Score: -0.77

References

1.  (2016)  Novel functionalized 5-(phenoxymethyl)-1,3-dioxane analogs exhibiting cytochrome p450 inhibition and their method of use, 
2. Blass, Benjamin E BE and 18 more authors.  2016-12-01  Design, synthesis, and evaluation of (2S,4R)-Ketoconazole sulfonamide analogs as potential treatments for Metabolic Syndrome.  [PMID:27789139]
3. Fehl, Charlie C and 5 more authors.  2018-06-14  Structure-Based Design of Inhibitors with Improved Selectivity for Steroidogenic Cytochrome P450 17A1 over Cytochrome P450 21A2.  [PMID:29792703]

Source